“jounce-therapeutics” Archives

in
Entry Author Date Location
Gilead Sciences Places $120M Bet on a Jounce Therapeutics Cancer Drug 09/01/20 San Francisco
Bio Roundup: Race and Pharma, ASCO Recap, Warp Speed Ahead & More 06/05/20 National
Cullinan Oncology Reels In $98M to Advance Cancer Drug Pipeline 06/04/20 Boston
Bio Roundup: Leiden’s Exit, Depression Data, a New Pricing Bill & More 07/26/19 National
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More 01/11/19 National
Bio Roundup: ASCO Abstracts, Migraine Drug Prices & “Blueprint” Fallout 05/18/18 National
Visterra, Braeburn Stumble After Solid ’17 Start for Bio IPOs 02/10/17 Boston
Bio Roundup: Trump News, Anthem’s Stand, Diversity by 2056 & More 01/27/17 National
Jounce Gets $102M As Biotech IPOs Gain Steam in ’17 01/27/17 Boston
First Trial Underway, Jounce Preps IPO To Fund Immuno-Oncology Work 01/03/17 Boston
MIT’s Jacks Leans on Disney Family, Not VCs, to Hatch New Startup 08/11/16 Boston
Biotech Roundup: Scangos’s Exit, Zafgen’s Shakeup, Jounce, Relypsa & More 07/22/16 National
Oncorus Bags $57M, Touts Next-Gen Take on Cancer-Fighting Viruses 07/19/16 Boston
With Celgene Deal, Jounce Lands $261M And a “Trusting Partner” 07/19/16 Boston
Atlas, Novartis Put $27M Into IFM to Battle Cancer, Autoimmune Diseases 06/22/16 Boston
With New Execs, Sanofi Backing, ImmuneXcite Begins Clinical Push 03/30/16 Boston
RaNA CEO Renaud Turns To A Former Backer To Lead $55M Series B 07/23/15 Boston
Ex-AstraZeneca Exec to Lead Surface’s “Next-Gen” Immuno-Oncology Plan 05/07/15 Boston
Adaptive Reels in Whopping $195M For Immuno-Sequencing Work 05/06/15 Seattle
With $46M Haul, MyoKardia Becomes Third Rock’s Latest IPO Prospect 04/30/15 San Francisco
East Coast Biotech Roundup: Forum, Crossovers, Immuno-Oncology & More 04/24/15 Boston
Crossovers Arm Jounce With $56M For “Next Step” Immuno-Oncology 04/23/15 Boston
Jounce Therapeutics Secures $56,000,000 Series B Funding 04/23/15 Boston
East Coast Biotech Roundup: Acceleron, Seres, Sage, & More 07/18/14 Boston
East Coast Biotech Roundup: Regeneron, Sarepta, Jounce, & More 07/11/14 Boston
New Jounce CEO Aims to Place the Right Immuno-Oncology Bets 07/11/14 Boston
Jounce Taps Merck Vet to Lead Cancer Drug Push 07/10/14 Boston
East Coast Biotech Roundup: Gerngross, Akili, Intercept, & More 01/10/14 Boston
Juno Therapeutics Grabs $120M to Coax Immune System to Fight Cancer 12/03/13 Seattle
Armo BioSciences Joins the Cancer Immunotherapy Party With $20M 11/25/13 San Francisco
Page 1 of 2 next page »